MedTrace Logo

MitraClip for Severe TR

NCT02863549 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2016-08-11

No results posted yet for this study

Summary

The aim of this study was to investigate the procedural feasibility and 30-day results of transcatheter tricuspid valve repair using the MitraClip® system (Abbott Vascular) in selected, highly symptomatic patients with severe tricuspid regurgitation (TR).

Conditions

  • Tricuspid Regurgitation

Interventions

DEVICE

MitraClip in tricuspid valve

MitraClip in tricuspid valve

Sponsors & Collaborators

  • LMU Klinikum

    lead OTHER

Principal Investigators

  • Daniel Braun, MD · Klinikum der Universität München

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02863549 on ClinicalTrials.gov